Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation

Petteri Rinne, Raquel Guillamat-Prats, Martina Rami, Laura Bindila, Larisa Ring, Leo-Pekka Lyytikainen, Emma Raitoharju, Niku Oksala, Terho Lehtimaki, Christian Weber, Emiel P. C. van der Vorst, Sabine Steffens*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2562-2575
Number of pages14
JournalArteriosclerosis Thrombosis and Vascular Biology
Volume38
Issue number11
DOIs
Publication statusPublished - Nov 2018

Keywords

  • atherosclerosis
  • cholesterol
  • fatty acids
  • inflammation
  • macrophages
  • RECEPTOR CLASS-B
  • DENSITY-LIPOPROTEIN RECEPTOR
  • APOPTOTIC CELL ACCUMULATION
  • CONTACT ALLERGIC DERMATITIS
  • MARROW-DERIVED CELLS
  • SCAVENGER RECEPTOR
  • CANNABINOID RECEPTOR
  • CHOLESTEROL TRANSPORT
  • REDUCES INFLAMMATION
  • CB2 RECEPTOR

Cite this

Rinne, P., Guillamat-Prats, R., Rami, M., Bindila, L., Ring, L., Lyytikainen, L-P., Raitoharju, E., Oksala, N., Lehtimaki, T., Weber, C., van der Vorst, E. P. C., & Steffens, S. (2018). Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation. Arteriosclerosis Thrombosis and Vascular Biology, 38(11), 2562-2575. https://doi.org/10.1161/ATVBAHA.118.311185